FY2025 EPS Estimates for TScan Therapeutics Cut by Wedbush
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Research analysts at Wedbush reduced their FY2025 earnings per share estimates for shares of TScan Therapeutics in a report released on Wednesday, March 5th. Wedbush analyst D. Nierengarten now expects that the company will earn ($0.98) per share for the year, down from their previous forecast of […]
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Research analysts at Wedbush reduced their FY2025 earnings per share estimates for shares of TScan Therapeutics in a report released on Wednesday, March 5th. Wedbush analyst D. Nierengarten now expects that the company will earn ($0.98) per share for the year, down from their previous forecast of […]
